You are on page 1of 107

Contemporary Clinical

Immunology and Serology

CHAPTER 22
Unit 1-Lecture 2
Basic Laboratory
Safety

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Basic Laboratory Safety

• Safety equipment
• Personal protection equipment (PPE)
• Safety procedures
• Safety and the law
• Needlestick injuries
• Postexposure treatment
• Chemical and radioactive hazards
• General safety
Contemporary Clinical Immunology and Serology
Kate Rittenhouse-Olson | Ernesto De Nardin
Common Laboratory Hazards

• Contamination
 Biological
 Radioactive
• Burns
 Chemical
 Heat sources

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Common Laboratory Hazards

• Sharps
 Needlesticks
• Other physical trauma

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Examples of Safety Equipment

• Warning labels
• Containment hoods
• Emergency showers
• Eye washes
• First-aid kits
• Waste-disposal containers
• PPE

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Warning Labels

• Identifies potential hazards


• Posted on
 Laboratory doors
 Laboratory equipment
 Containers of chemicals
 Biological samples
 Radioactive materials

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
National Fire Protection
Association (NFPA) Diamond
• Health risks (blue)
• Flammability risks
(red)
• Reactivity risks
(yellow)
• Special risks
(white)

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
National Fire Protection
Association (NFPA) Diamond
• Numbers in each color indicate level of
risk
 0 in red indicates nonflammable
reagents
 4 in red indicates dispersal in air, burns
at all temps
• Contact information

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Chemical Containment Hoods

• "Fume hoods"
• OSHA
 Device enclosed on five sides
• Partial covering or sash
• Work is done within the hood
• Technician's arms/hands only inside
hood

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Chemical Containment Hoods

• Negative pressure
 Air drawn in from lab, exhausts into
separate air-handling system
 Individuals not exposed to fumes from
reagents
• National Research Council
 People working together in fume hood
• 2.5 linear feet of space

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Chemical Containment Hoods

• Ventilate 60–100 linear feet per minute


 Not too high ( turbulence)
• Lab hood as work space, not storage
space
 Clutter causes accidents and increases
chance of fire when working with
flammable reagents

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Figure 22.2
Typical laboratory chemical hood.

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Biological Containment Hoods

• Protects the operator


• Avoids contaminating sample/specimen
• Air through HEPA filter (0.3 μm)

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Laminar Flow Hood

• Forced air constantly runs downward at


the opening of the hood
 Prevents entry or exit of contaminating
particles
• Hoods can be designed just to protect
sample from outside contamination and
may not protect room from the sample

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Laminar Flow Hood

• Germicidal ultraviolet lights inside hood


 Maintain sterile conditions
 Turned off when specimen is handled
• Biological safety cabinet
 Appropriate air flow
• Position—no drafts from doors, windows,
or traffic

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Figure 22.3
Laminar flow hood.

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Emergency Showers and
Eye Wash Stations
• Operator contamination
 Large spills on lab worker
 Clothing set on fire by flammable
chemicals
 Splashes in eyes

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Emergency Showers and
Eye Wash Stations
• Equipment location
 Unrestricted pathway
• Urgent need to shower or eye wash
• Less than 10 seconds to reach, if strong
acids or bases are used
• Less than 100 feet from injury

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Figure 22.4
Typical laboratory emergency shower.

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Eye Wash Stations

• Design
 Able to operate with impaired vision
 Large handles
 Provide copious amounts of water
 Directed to face, eyes

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Eye Wash Stations

• Two types
 Plumbing permanently connected to wall
 Dispense fluid by gravity flow
• Devices contain water or saline

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Figure 22.5
Emergency eyewash station.

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Safety Containers

• Safe and proper disposal


 Biological hazards
 Hypodermic needles, syringes
 Glass and sharps
• Do not discard in conventional trash
• Collect and process according to
regulations

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Sharps Safety Containers

• Puncture proof that can be autoclaved


• Openings that do not allow retrieval
once items are disposed
• No overfill
• Other sharps (broken glass, surgical
blades, glass slides)
 Dispose in puncture-proof containers
 Containers can also be autoclaved

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Figure 22.6
Typical disposal container for sharps such as needles.

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Figure 22.7
Typical container for the disposal of broken glass or other sharps.

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Safety Containers

• Disposing biological materials


 Leakproof, autoclavable plastic bag
 Clearly labeled with biohazard warning
 Once autoclaved dispose in labeled
biohazard disposal boxes

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Figure 22.8
Typical box used for the disposal of bagged, sealed, and autoclaved biological waste.

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Personal Protection Equipment

• Goggles
• Face shields
• Lab coats
• Lab gowns
• Face masks
• Gloves

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Figure 22.9
Operator using personal protection equipment.

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Laboratory Coats and Gowns

• Disposable or multiple use


• Prevent biological contamination (body
fluids [blood, urine, saliva, excretions])
to operator and clothing
• Fully buttoned
• Preferably fluid resistant

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Laboratory Coats and Gowns

• Tight sleeves
 Fit beneath the gloves
 Removed and changed patient to patient
(if patient contact is required)
• Wash frequently if multiple use
• Single use
 Discard immediately after use

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Gloves

• Different types and sizes


 Sterile surgical gloves
 Nonsurgical latex gloves
 Simple vinyl gloves
• Nonsterile gloves are sufficient for most
labs
• Protection from blood, body fluids,
excreta, other potentially contaminated
items
Contemporary Clinical Immunology and Serology
Kate Rittenhouse-Olson | Ernesto De Nardin
Gloves

• Gloves alone are not sufficient for


protection
• Wash hands thoroughly both before
and after wearing gloves
• Change gloves from patient to patient
• Remove immediately after use and
dispose

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Gloves

• Snug, well-fitting
• Extend over cuffs or sleeves of lab
coats and gowns to prevent
contamination
• Never kept on when leaving lab or
when changing from one station of lab
to another

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Gloves

• Never worn while:


 Opening doors
 Touching environmental surfaces
 Operating lab equipment away from
operating station

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Latex Sensitivity

• Latex
 Most common glove material
 Allergy
• Type 1 hypersensitivity most common
• Reactions—red, itchy skin, hives,
coughing, wheezing

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Latex Sensitivity

• Latex
 Allergy
• Avoid using in areas where gloves are
changed
• Type IV hypersensitivity reactions
(contact dermatitis)

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Masks, Goggles, and Face Shields

• Protects operator from splashes


 Biological samples
 Potentially airborne aerosols and
pathogens

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Masks, Goggles, and Face Shields

• Worn when manipulating biological


samples
 Prevent contamination of mucosa
(mouth, nose, eyes)
• Alternative to goggles or face shields
 Lab bench shield

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Personal Care and Behavior

• Tie back long hair


 Reduces risk of contamination
 Reduces risk of entrapment in moving
equipment
• Closed-toe shoes at all times
• Nothing placed in mouth while in lab

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Vaccination

• OSHA 1991
 Hepatitis B vaccine
• Employers must offer without charge to
those at risk
 Rubella, mumps, measles, influenza
• Recommends vaccinate hospital
employees
• Especially women of childbearing years

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Universal Precautions

• Assume all patients and samples are


potentially infectious and possible
carriers

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Universal Precautions

• Guidelines
 Wear PPE (gloves, masks, coats, or
gowns)
• When collecting blood or handling body
fluids that may be contaminated with
blood
• When there is a possibility of blood
splashing on mucosal surfaces

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Universal Precautions

• Guidelines extended to other body


fluids
 Semen
 Vaginal secretions
 Synovial fluid
 Amniotic fluid

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Universal Precautions

• Guidelines extended to other body


fluids
 Cerebrospinal fluid
 Pleural fluid
 Peritoneal fluid
 Pericardial fluid

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Universal Precautions Guidelines

• Wash hands after removing gloves


• Never pipette by mouth
• Transport sample in leakproof container
with lid
• Decontaminate work surfaces after
working with blood or body fluid

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Universal Precautions Guidelines

• Disinfect biological spills with a fresh


solution of 1:10 dilution bleach or with
commercial disinfectant
• Decontaminate material before disposal
• Do not wear protective clothing outside
lab

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Hand Washing

• Basic yet most effective safety


procedure

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Hand Washing

• APIC and CDC guidelines


1. Wet hands with warm water
2. Apply soap and spread over hands
3. Rub hands together for 20 seconds,
hard enough to generate friction; rub
all surfaces and under fingernails
• Wash from wrist area to tips of fingers

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Hand Washing

• APIC and CDC guidelines


4. Rinse thoroughly
• Water flowing in downward direction
(wrists to fingers), carrying
contaminated water away from operator
and into sink
5. Dry with towels
6. Turn off sink with a towel

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Hand Washing

• Wash any time contamination is


suspected
• Wash before and after wearing gloves
• Wash between patients and between
different samples

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Hand Washing

• Wash when gloves are changed


• Wash before leaving lab, before food
and drink handling, and after using
restrooms

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Sample Handling

• Assume every sample is source of


contamination
• Spread of infection follows a specific
pattern
 Source
 Method of transmission
 Host

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Sample Handling

• Most common source of infection in


clinical lab
 Biological specimens

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
OSHA Directives for Laboratory
Behavior
• No mouth pipetting
• No eating, drinking, smoking
• No applying of cosmetics or lip balm
• No handling contact lenses in lab

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
OSHA Directives for Laboratory
Behavior
• No storage of food or drink in lab
refrigerators or lab bench tops
• Chipped or broken glassware should be
discarded

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Safety and the Law

• OSHA
 Occupational Exposure to Bloodborne
Pathogen (BBP) Standard (29 CFR
1910.1930)
• Regulations to instruct and protect health
workers about exposure to BBPs
• Develop and implement exposure control
plan

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Safety and the Law

• OSHA
 Occupational Exposure to Bloodborne
Pathogen (BBP) Standard (29 CFR
1910.1930)
• Regulations to instruct and protect health
workers about exposure to BBPs
• Provide health workers with free lab coats,
gowns, and other personal safety
equipment

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Safety and the Law

• OSHA
 Occupational Exposure to Bloodborne
Pathogen (BBP) Standard (29 CFR
1910.1930)
• Regulations to instruct and protect health
workers about exposure to BBPs
• General lab safety equipment (warning
labels)

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
29 CFR 1910.1930 Regulations

• No eating and drinking in lab


• Immunization against hep B must be
available, no charge
• Laundering services must be provided
free for multiple-use items (coats,
other protective clothing)
• Maintain records of health workers
training

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
29 CFR 1910.1930 Regulations

• Establish well-defined procedures and


follow-up should worker be exposed to
BBP
 Pathogenic microorganisms present in
human blood can cause disease in
humans, not limited to
• Hepatitis B virus (HBV)
• Human immunodeficiency virus (HIV)

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Needlestick Injury Protocols

• Major pathogens of concern


 HIV
 Hepatitis B
• Vaccination reduces risk 90–95%
• Survives on surfaces > 1 week
• Contamination by inanimate object can
occur

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Needlestick Injury Protocols

• Major pathogens of concern


 Hepatitis C
• Risk 0–7%
 Hepatitis D
• Minor concern
 Tetanus
• http://www.ccohs.ca/oshanswers/disea
ses/needlestick_injuries.html

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Transmission Rate

• Rate of occupational transmission


 HIV
• 0.3% needlestick
• 0.09% mucous membrane exposure
 Hepatitis B
• 6–24% if nonimmunized
 Hepatitis C
• 1–10%

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Treatment

• Needlestick
 Squeeze one drop blood
 Wash hands
 Apply alcohol wipe
 Stop
• No harsh manner; don't want white cells
to area

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Treatment

• Mucous membrane
 Wash/flush with large amounts of saline

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Report

• Report to supervisor
• Go to employee clinic
 Need history to determine risk
• Immunization record (hepatitis and
tetanus)
• Previous occupational exposure to body
fluids
• IV drug use
• Sexual history

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Report

• Go to employee clinic
 Need history to determine risk
• Body piercing or tattooing
• Receiving blood or blood products
• Dialysis history
• Travel outside U.S. within last year
 Physical for baseline lung, liver, lymph
node status

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Risk Factors

• Failure to follow Universal precautions


• Use of equipment without safety
feature
• Performing exposure-prone tasks

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Laboratory Testing

• Source patient with consent


 HIV
 Hepatitis B
 Hepatitis C
 AST (aspartate aminotransferase)
 ALT (alanine aminotransferase)
 Alkaline phosphatase

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Laboratory Testing

• Health-care worker
 Hepatitis B surface antibody
• Did vaccine work?
 HIV
 Hepatitis C antibody testing
• Baseline
• 2 weeks
• 4 weeks
• 8 weeks
Contemporary Clinical Immunology and Serology
Kate Rittenhouse-Olson | Ernesto De Nardin
Laboratory Testing

• Prior to initiating retroviral therapy


 Stat pregnancy test
 Liver function
• AST/ALT, alkaline phosphatase, bilirubin

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Laboratory Testing

• Prior to initiating retroviral therapy


 Kidney function
• Serum creatinine/BUN levels, urinalysis
with microscopic analysis
 General health
• CBC with diff and platelets

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Immediate Care

• Irrigate and clean wound


• Tetanus shot
• Hepatitis B prophylaxis if not
immunized
• Hepatitis A prophylaxis (rarely needed)
• HIV risk assessment

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Figure 22.10
Different exposure codes for potential HIV infection.

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Figure 22.11
Risk assessment codes for an HIV-infected patient.

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Postexposure Prophylaxis (PEP)

• Basic regime four weeks


 Zidovudine (AZT) and lamivudine (3TC),
a nucleoside analog reverse
transcriptase inhibitor

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Postexposure Prophylaxis (PEP)

• Expanded regime
 Zidovudine (AZT) and lamivudine (3TC)
 Indinavir (protease inhibitor)
 Nelfinavir (protease inhibitor)
• Interferon ribavirin
 Decreases risk by 40%

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
After Postexposure Prophylaxis
(PEP)
• Abstain from sex
 6 months or until third negative test
• Breast feeding discouraged
• Do not donate blood
• Receive follow-up care for 6 months to
determine seroconversion status

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Needlestick with Hepatitis C risk

• 1.8% chance of seroconverting if


needlestick
• Splash to eyes or mouth risk very low
• Test both for anti-HCV and ALT
• Follow 4–6 months to look for antibody

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Needlestick with Hepatitis C risk

• Follow 4–6 weeks if testing for HCV


RNA
• Run confirmatory test
• http://www.cdc.gov/hepatitis/HCV/HCV
faq.htm

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Prevent Exposures

• Use safer techniques


• Do not recap needles
• Dispose used needles in sharps
containers
• Use devices with safety features
• Wear gloves
• Wear eye and face protection
• Wear gowns

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Other Diseases Spread (Rarely) by
Needlestick
• Blastomycosis
• Brucellosis
• Cryptococcosis
• Diptheria
• Cutaneous gonorrhea
• Herpes
• Malaria
• Mycobacteriosis
Contemporary Clinical Immunology and Serology
Kate Rittenhouse-Olson | Ernesto De Nardin
Other Diseases Spread (Rarely) by
Needlestick
• Mycoplasma caviae
• Rocky mountain spotted fever
• Sporotrichosis
• S. aureus
• S. Pyogenes
• Syphilis
• Toxoplasmosis
• Tuberculosis
Contemporary Clinical Immunology and Serology
Kate Rittenhouse-Olson | Ernesto De Nardin
Chemical Hazards

• PPE (laboratory coats, masks, face


shields, gloves) to avoid contact with
skin, mucous surfaces, and clothing
• Handle flammable or toxic vapor
chemicals inside fume hood
• Read labels on reagent bottles
 Learn potential hazards and proper
handling instructions
• Material Safety Data Sheet (MSDS)
Contemporary Clinical Immunology and Serology
Kate Rittenhouse-Olson | Ernesto De Nardin
Material Safety Data Sheet
(MSDS)
• Provided by manufacturer
• Chemical properties

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Material Safety Data Sheet
(MSDS)
• Physical properties
 Melting point
 Boiling point
 Flash point
 Reactivity
 Toxicity
 Health effects

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Material Safety Data Sheet
(MSDS)
• Other info
 First-aid procedures
 Specific protective equipment
 Storage and disposal
 How to handle spills

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Chemical Spills

• Wash affected area immediately


 Copious amounts of water for 15–20
minutes
• First aid should follow

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Chemical Spills

• Be aware of shower/eye-washing
station locations
 Practice reaching them quickly, even
under impaired conditions
• Use appropriate "spill kit" to clean spills
 MSDS has what absorbent or
neutralizing material to use

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Liquid Nitrogen

• Used to preserve cells and tissues


• If spilled on skin, can cause cold-
contact burns

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Liquid Nitrogen

• Liquid nitrogen
 Room temperature—quickly becomes
gas
• Liquid to gas volume ratio is 1:694
 Replaces oxygen in room; acts as
asphyxiant
 Dangerous when room oxygen levels
< 16%
 Store with oxygen sensor

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Radioactive Hazards

• Radioactivity in routine clinical lab


assays very low
• Effect of radiation is cumulative
• Avoid or minimize exposure
• Nuclear Regulatory Commission (NRC)
regulates radioactive materials

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
Nuclear Regulatory Commission
(NRC)
• Dictates amount of radiation allowed in
lab
• Regulates different isotopes used for
assays
• Regulates monitoring, tracking, and
disposal of radioactive materials

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
NRC Regulations

• Labs are required to keep records of


 Quantity of materials used
 Type of isotopes used
 Disposal of waste
 Purchase of materials
 Disposal of unused materials
• Records are kept in a book or binder
provided by the radiation protection
services of the lab or hospital
Contemporary Clinical Immunology and Serology
Kate Rittenhouse-Olson | Ernesto De Nardin
Figure 22.12
Radioactive protection services record book and two badge-style dosimeters.

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
NRC Regulations

• PPE (gloves, masks, and gowns) must


be used
• Dosimeters
 Devices that record amount of
radioactivity
 Assigned to single individual user
 Worn as badges or rings
 Periodically monitored by radiation
protection services
Contemporary Clinical Immunology and Serology
Kate Rittenhouse-Olson | Ernesto De Nardin
NRC Regulations

• Work is carried out in designated areas


• Areas are labeled for use of radioactive
materials
 Monitored routinely (1x month) for
contamination with periodic swab tests

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
NRC Regulations

• Results recorded in radiation-protecting


services record book
• Disposal is carefully regulated and
monitored
 Both local regulation and NRC
• Amount of radioactivity and
radioisotopes involved varies according
to type of material (solid, liquid,
volatile chemical)
Contemporary Clinical Immunology and Serology
Kate Rittenhouse-Olson | Ernesto De Nardin
General Safety

• Workers are trained in how to use


safety equipment
• Know the location of fire blankets, fire
extinguishers, showers, eye wash
stations, decontaminating solutions,
spill kits, and first-aid kits

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
General Safety

• Understand fire evacuation route


• Designate an evacuation meeting place
 "Role call" (ascertain if anyone unable to
leave building)
• Electrical equipment should not be
plugged into extension cords or into
"gang" plugs

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
What's Wrong with this Picture?

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
What's Wrong with this Picture?

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
What's Wrong with this Picture?

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
What's Wrong with this Picture?

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin
What's Wrong with this Picture?

Contemporary Clinical Immunology and Serology


Kate Rittenhouse-Olson | Ernesto De Nardin

You might also like